- €11.44m
- €464.25m
- €201.64m
- 44
- 95
- 46
- 68
R2019 March 31st | 2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 187 | 202 | 281 | 290 | 202 |
Cost of Revenue | |||||
Gross Profit | 14.3 | 3.64 | 67.3 | -2.19 | -78.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 171 | 183 | 258 | 268 | 195 |
Operating Profit | 16.3 | 18.4 | 22.3 | 22.3 | 6.31 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 8.81 | 1.15 | 4.26 | 3.18 | -26 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6.24 | 0.408 | 2.77 | 1.18 | -25.4 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 6.64 | 0.067 | 4.32 | 2.4 | -20.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 6.64 | 0.067 | 4.32 | 2.42 | -20.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -5.7 | -14.9 | 3.02 | -17.5 | -45.2 |
Dividends per Share |